Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Do COVID-Unit caregivers face higher infection risk? study aims to find out

NCT ID NCT04353323

Knowledge-focused Sponsor: University Hospital, Limoges Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study investigates whether hospital caregivers working in COVID-19 patient areas are more likely to get infected than those in non-COVID areas. Researchers will take blood samples from participants on day 0, day 15, and day 30 to check for antibodies that signal past infection. The goal is to understand the real risk of infection for healthcare workers and help reduce anxiety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the study shows similar infection rates, it could ease anxiety among healthcare workers and guide infection control policies.
What could go wrong
This is a small, observational study with blood tests over 30 days, so results may not apply broadly or confirm long-term risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Expected to start

May 2020

An estimate. Start dates often move.

Expected to finish

Dec 2020

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Caregivers staff assigned to a non-intensive care COVID service * Or caregiversg staff assigned to a non-COVID adult service * Or caregivers staff assigned to a non-COVID pediatric service

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * caregivers staff assigned to a non-intensive care COVID service * or caregivers staff assigned to a non-COVID adult service * or caregivers staff assigned to a non-COVID pediatric service * Age \> = 18 years old * With health insurance * Express consent Exclusion Criteria: * Protected persons * Refusal to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infection, COVID-19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

COVID-19 Infections

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infection, COVID-19

Contacts and locations

Locations

  • CHU de Limoges

    Limoges, France